USANA Health Sciences Inc (USNA)
Cash ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 181,768 | 364,889 | 332,423 | 328,336 | 330,420 | 307,081 | 300,183 | 295,454 | 288,420 | 246,879 | 230,370 | 237,753 | 239,832 | 248,695 | 265,368 | 256,964 | 311,917 | 278,418 | 227,368 | 194,098 |
| Short-term investments | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 139,625 | 114,779 | 103,896 | 112,631 | 118,845 | 112,559 | 113,839 | 130,222 | 143,833 | 125,846 | 133,594 | 157,967 | 160,790 | 157,964 | 153,000 | 151,452 | 168,073 | 160,863 | 139,717 | 124,504 |
| Cash ratio | 1.30 | 3.18 | 3.20 | 2.92 | 2.78 | 2.73 | 2.64 | 2.27 | 2.01 | 1.96 | 1.72 | 1.51 | 1.49 | 1.57 | 1.73 | 1.70 | 1.86 | 1.73 | 1.63 | 1.56 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($181,768K
+ $—K)
÷ $139,625K
= 1.30
The cash ratio of USANA Health Sciences Inc has shown fluctuations over the reporting periods ranging from March 31, 2020, to December 31, 2024. The cash ratio represents the company's ability to cover its short-term liabilities using its cash and cash equivalents.
The cash ratio has generally been healthy and above 1, indicating that the company has sufficient cash on hand to cover its short-term obligations. The ratio has shown an increasing trend from 1.56 on March 31, 2020, reaching a peak of 3.20 on June 30, 2024.
However, there are some periods where the cash ratio dipped notably, such as December 31, 2021, when it decreased to 1.49. This could indicate a temporary strain on liquidity during that particular period.
Overall, the increasing trend in the cash ratio reflects a positive liquidity position for USANA Health Sciences Inc, suggesting that the company has been effective in managing its cash resources to meet its short-term obligations.